Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...
Vous n'êtes pas connecté
Optiscan Imaging has received the nod of approval to start taking in-human images during surgery for breast cancer patients using its “InVue” technology.
Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...
Optiscan’s latest study is now underway, using its InVue and InForm devices to help surgeons assess breast cancer margins in ...
Optiscan Imaging has inked a game-changing deal with US drugmaker Long Grove to fast-track FDA approvals and unlock new surgical uses for its...
Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M), Spain, has developed a tool to monitor...
KUALA LUMPUR: FGV Holdings Bhd received shareholders’ nod for its proposed acquisition of the remaining interests in eight subsidiaries from...
KUALA LUMPUR: FGV Holdings Bhd received shareholders’ nod for its proposed acquisition of the remaining interests in eight subsidiaries from...
Charity Breast Cancer Now says the process for NHS drug approval is ‘unfair’...
Charity Breast Cancer Now says the process for NHS drug approval is ‘unfair’...
Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast cancer cells in early tests....
Since their discovery by Wilhelm Roentgen in 1895, X-rays have become a staple of modern medical care, from imaging teeth and broken bones to...